David Shaw’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-23,000
Closed -$866K 3958
2019
Q4
$866K Buy
+23,000
New +$1.03M ﹤0.01% 3081
2019
Q2
Sell
-4,100
Closed -$283K 3688
2019
Q1
$283K Sell
4,100
-8,300
-67% -$556K ﹤0.01% 3243
2018
Q4
$740K Sell
12,400
-15,800
-56% -$1.36M ﹤0.01% 2859
2018
Q3
$3.27M Hold
28,200
﹤0.01% 1857
2018
Q2
$3.56M Buy
+28,200
New +$3.43M ﹤0.01% 1778
2015
Q3
Sell
-20,800
Closed -$2.37M 3737
2015
Q2
$2.37M Sell
20,800
-10,200
-33% -$1.24M ﹤0.01% 2056
2015
Q1
$3.24M Buy
31,000
+20,800
+204% +$2.22M 0.01% 1683
2014
Q4
$1.23M Buy
10,200
+200
+2% +$26.3K ﹤0.01% 2666
2014
Q3
$1.46M Buy
+10,000
New +$1.54M ﹤0.01% 2479
2014
Q1
Sell
-10,000
Closed -$1.91M 4315
2013
Q4
$1.91M Sell
10,000
-10,000
-50% -$1.86M ﹤0.01% 2569
2013
Q3
$3.38M Hold
20,000
0.01% 1958
2013
Q2
$3.03M Buy
+20,000
New +$2.83M 0.01% 1733

Other funds holding CLB

David Shaw's CLB Position: Q2 2026 in Review

David Shaw increased its Core Laboratories (CLB) stake by 109% in Q2 2026, buying an estimated $1.85M and bringing the position to 248,070 shares worth $2.89M. The position accounts for ﹤0.01% of the portfolio, ranked #2887.

David Shaw first reported a position in CLB in Q2 2013 and has held it in 44 quarters since. The position peaked at $12.8M in Q2 2014. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • David Shaw held 248,070 shares of Core Laboratories worth $2.89M as of Q2 2026.
  • David Shaw bought 129,644 Core Laboratories shares in Q2 2026, an estimated $1.85M.
  • Core Laboratories made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #2887 holding.
  • David Shaw first reported a position in Core Laboratories in Q2 2013 and has held it in 44 quarters since.
  • David Shaw's Core Laboratories position peaked at $12.8M in Q2 2014.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.